Greg Went

Greg Went is a highly experienced executive in the biosciences industry. Greg currently holds the position of Chief Executive Officer and Chairman at Dextera Biosciences. With a background in Chemical Engineering, Greg co-founded and led various companies such as SynaVir, Adamas Pharmaceuticals, Inc., Tethys Bioscience, Inc., DNA Sciences, and CuraGen Corporation. Their expertise includes genomics, DNA detection, bioinformatics, and business development. Greg's leadership has been instrumental in creating successful partnerships and driving internal R&D programs within the companies Greg has been involved with.